Literature DB >> 27644084

Correlation between Cyr61 expression and clinicopathologic parameters in adenomyosis.

Duo Zhang1, Wei Xia1, Tong Tong1, Cheng Li1, Wei Shi1, Ming-Xing Yan1, Rui-Hong Xue1, Xiao-Ming Guan2, Jian Zhang3.   

Abstract

Adenomyosis, a benign invasion of endometrium, is closely related to endometriosis. Cysteine-rich 61 (Cyr61), a protein present in all endometrial tissues and menstrual effluents, is known to be associated with endometriosis. However, its relation to adenomyosis has not been determined thus far. Therefore, here, we aimed to investigate the expression of Cyr61 protein in adenomyosis and determine the correlation between Cyr61 expression and clinicopathologic parameters in patients with adenomyosis. One hundred and twenty patients with histologically diagnosed adenomyosis, who underwent hysterectomy for non-endometrial disease were enrolled in this study. Patients were interviewed using a standard questionnaire consisting of sociodemographic characteristics and reproduction history. The severity of dysmenorrhea and menorrhagia was evaluated using the visual analogue scale (VAS) and pictorial blood-loss assessment chart (PBAC). Samples of serum, endometrial tissue, and peritoneal fluid were collected, and Cyr61 mRNA levels were determined by RT-PCR. The Cyr61 protein levels in endometrial and ectopic lesions were determined by immunohistochemistry and those in serum and peritoneal fluid, by ELISA. We found that expression of Cyr61 was higher in the ectopic endometrium than in the eutopic endometrium. Cyr61 expression in the endometrium was correlated with age, number of natural labors, PBAC score, VAS score, uterine volume, adenomyosis type, and concurrent endometriosis. The Cyr61 protein level in the ascites was higher than that in serum, and no correlation existed between them. Our results suggest that the expression of Cyr61 may be indirectly related to the degree of dysmenorrhea and Cyr61 may be involved in the pathogenesis of adenomyosis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adenomyosis; Cyr61; Ectopic; Endometrium; Eutopic

Mesh:

Substances:

Year:  2016        PMID: 27644084     DOI: 10.1016/j.jri.2016.08.004

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  2 in total

1.  Anti-Inflammatory Activity of Sanjie Zhentong Capsule Assessed By Network Pharmacology Analysis of Adenomyosis Treatment.

Authors:  Li Du; De-Hui Du; Biao Chen; Yue Ding; Tong Zhang; Wei Xiao
Journal:  Drug Des Devel Ther       Date:  2020-02-20       Impact factor: 4.162

2.  RhoA/ROCK/ARHGAP26 signaling in the eutopic and ectopic endometrium is involved in clinical characteristics of adenomyosis.

Authors:  Caixia Jiang; Wei Gong; Rong Chen; Huihui Ke; Xiaoyan Qu; Weihong Yang; Zhongping Cheng
Journal:  J Int Med Res       Date:  2018-11-02       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.